NASDAQ: ASLNAslan Pharmaceuticals Ltd Stock Ownership - Who owns Aslan Pharmaceuticals?
Insider buying vs selling
Have Aslan Pharmaceuticals Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ASLN insiders and whales buy or sell their stock.
ASLN Shareholders
What type of owners hold Aslan Pharmaceuticals Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bvf Inc | 0.24% | 1,049,999 | $525.00k | Institution |
| Ubs Group Ag | 0.14% | 625,000 | $312.50k | Institution |
| Citadel Advisors LLC | 0.11% | 482,963 | $241.48k | Institution |
| Shay Capital LLC | 0.09% | 400,000 | $200.00k | Institution |
| Sio Capital Management LLC | 0.06% | 254,150 | $127.08k | Institution |
| Renaissance Technologies LLC | 0.04% | 172,801 | $86.40k | Institution |
| Parkman Healthcare Partners LLC | 0.03% | 110,658 | $55.33k | Institution |
| Landscape Capital Management LLC | 0.02% | 83,259 | $41.63k | Institution |
| Millennium Management LLC | 0.02% | 80,362 | $40.18k | Institution |
| Waterfront Wealth Inc | 0.01% | 40,941 | $20.47k | Institution |
ASLN vs Biotech Stocks
Aslan Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.